Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Manette A.W. Dinnessen; Carolien C.H.M. Maas; Sanne H. Tonino; Otto Visser; Eduardus F.M. Posthuma; Nicole M.A. Blijlevens; Marie José Kersten; Pieternella J. Lugtenburg; Avinash G. Dinmohamed

doi:10.1038/s41375-022-01535-y

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Manette A.W. Dinnessen^*
, Carolien C.H.M. Maas
, Sanne H. Tonino
, Otto Visser
, Eduardus F.M. Posthuma
, Nicole M.A. Blijlevens
, Marie José Kersten
, Pieternella J. Lugtenburg
, Avinash G. Dinmohamed

^*Corresponding author for this work

Netherlands Comprehensive Cancer Organization (IKNL)
University of Amsterdam
Reinier de Graaf Groep
Leiden University Medical Centre
Radboud University Medical Center
LYMMCARE (Lymphoma and Myeloma Center Amsterdam)
Cancer Center Amsterdam (CCA)

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	1416-1420
Number of pages	5
Journal	Leukemia
Volume	36
Issue number	5
Early online date	4 Mar 2022
DOIs	https://doi.org/10.1038/s41375-022-01535-y
Publication status	Published - May 2022

Bibliographical note

Funding Information: MJK: research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene. SHT: honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead. PJL: research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene. The other authors have no conflict of interest.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41375-022-01535-y

Cite this

Dinnessen, M. A. W., Maas, C. C. H. M., Tonino, S. H., Visser, O., Posthuma, E. F. M., Blijlevens, N. M. A., Kersten, M. J., Lugtenburg, P. J., & Dinmohamed, A. G. (2022). Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era. Leukemia, 36(5), 1416-1420. https://doi.org/10.1038/s41375-022-01535-y

@article{11662e63b9ca438eb66bcb1cf67910ed,

title = "Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era",

author = "Dinnessen, \{Manette A.W.\} and Maas, \{Carolien C.H.M.\} and Tonino, \{Sanne H.\} and Otto Visser and Posthuma, \{Eduardus F.M.\} and Blijlevens, \{Nicole M.A.\} and Kersten, \{Marie Jos{\'e}\} and Lugtenburg, \{Pieternella J.\} and Dinmohamed, \{Avinash G.\}",

note = "Funding Information: MJK: research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene. SHT: honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead. PJL: research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene. The other authors have no conflict of interest. ",

year = "2022",

month = may,

doi = "10.1038/s41375-022-01535-y",

language = "English",

volume = "36",

pages = "1416--1420",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "5",

}

Dinnessen, MAW, Maas, CCHM, Tonino, SH, Visser, O, Posthuma, EFM, Blijlevens, NMA, Kersten, MJ, Lugtenburg, PJ & Dinmohamed, AG 2022, 'Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era', Leukemia, vol. 36, no. 5, pp. 1416-1420. https://doi.org/10.1038/s41375-022-01535-y

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era. / Dinnessen, Manette A.W.; Maas, Carolien C.H.M.; Tonino, Sanne H. et al.
In: Leukemia, Vol. 36, No. 5, 05.2022, p. 1416-1420.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups

T2 - a population-based study in the pre- and post-rituximab era

AU - Dinnessen, Manette A.W.

AU - Maas, Carolien C.H.M.

AU - Tonino, Sanne H.

AU - Visser, Otto

AU - Posthuma, Eduardus F.M.

AU - Blijlevens, Nicole M.A.

AU - Kersten, Marie José

AU - Lugtenburg, Pieternella J.

AU - Dinmohamed, Avinash G.

N1 - Funding Information: MJK: research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene. SHT: honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead. PJL: research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene. The other authors have no conflict of interest.

PY - 2022/5

Y1 - 2022/5

UR - https://www.scopus.com/pages/publications/85125675692

U2 - 10.1038/s41375-022-01535-y

DO - 10.1038/s41375-022-01535-y

M3 - Comment/Letter to the editor

C2 - 35246605

AN - SCOPUS:85125675692

SN - 0887-6924

VL - 36

SP - 1416

EP - 1420

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this